Royalty Pharma: Which ETFs hold the stock?
ETFs and index funds whose holdings recorded by us include Royalty Pharma – with weighting and costs. Usually only each fund’s largest holdings are recorded, so the list is not complete. ISIN GB00BMVP7Y09
At a glance
Royalty Pharma (ISIN GB00BMVP7Y09) is held by 5 of the ETFs and index funds we analyse. The largest weighting is in L&G Pharma Breakthrough UCITS ETF at 3.18%.
Funds holding Royalty Pharma: 5
| Fund | Weight | TER | Details |
|---|---|---|---|
|
L&G Pharma Breakthrough UCITS ETF
IE00BF0H7608
|
3.18%
|
0.49% | Details |
|
iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)
IE00BDZVHG35
|
1.84%
|
0.35% | Details |
|
Invesco Nasdaq Biotech UCITS ETF
IE00BQ70R696
|
1.84%
|
0.40% | Details |
|
iShares Nasdaq US Biotechnology UCITS ETF
IE00BYXG2H39
|
1.84%
|
0.35% | Details |
|
VanEck Morningstar US SMID Moat UCITS ETF A
IE000SBU19F7
|
1.49%
|
0.49% | Details |
Analysis tip
A large weighting of a single stock can increase an ETF's volatility. Check how much your overall portfolio depends on individual companies.
Highest weighting
3.18%